These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Diminished selection for thymidine-analog mutations associated with the presence of M184V in Ethiopian children infected with HIV subtype C receiving lamivudine-containing therapy. Averbuch D; Schapiro JM; Lanier ER; Gradstein S; Gottesman G; Kedem E; Einhorn M; Grisaru-Soen G; Ofir M; Engelhard D; Grossman Z Pediatr Infect Dis J; 2006 Nov; 25(11):1049-56. PubMed ID: 17072129 [TBL] [Abstract][Full Text] [Related]
43. [Fatal lactic acidosis in a patient with acquired immunodeficiency syndrome treated with highly active antiretroviral therapy. Report of a case]. Lasso M; Pérez J; Noriega LM; Northland R Rev Med Chil; 2000 Oct; 128(10):1139-43. PubMed ID: 11349514 [TBL] [Abstract][Full Text] [Related]
44. Exploratory study comparing the metabolic toxicities of a lopinavir/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir/ritonavir plus zidovudine/lamivudine nucleoside regimen. Cameron DW; Becker S; King MS; da Silva B; Klein C; Tokimoto D; Foit C; Calhoun D; Bernstein B; Hanna GJ J Antimicrob Chemother; 2007 May; 59(5):957-63. PubMed ID: 17350990 [TBL] [Abstract][Full Text] [Related]
45. Lactic acidosis in an HIV-infected patient receiving highly active antiretroviral therapy. Patel V; Hedayati SS Nat Clin Pract Nephrol; 2006 Feb; 2(2):109-14; quiz 115. PubMed ID: 16932402 [TBL] [Abstract][Full Text] [Related]
46. Evidence for mitochondrial toxicity: lactic acidosis as proof of concept. Brinkman K J HIV Ther; 2001 Mar; 6(1):13-6. PubMed ID: 11501196 [No Abstract] [Full Text] [Related]
47. Fatal lactic acidosis and mimicking Guillain-Barré syndrome in an adolescent with human immunodeficiency virus infection. Rosso R; Di Biagio A; Ferrazin A; Bassetti M; Ciravegna BW; Bassetti D Pediatr Infect Dis J; 2003 Jul; 22(7):668-70. PubMed ID: 12886900 [TBL] [Abstract][Full Text] [Related]
48. Risk factors for and clinical characteristics of severe hyperlactataemia in patients receiving antiretroviral therapy: a case-control study. Osler M; Stead D; Rebe K; Meintjes G; Boulle A HIV Med; 2010 Feb; 11(2):121-9. PubMed ID: 19702629 [TBL] [Abstract][Full Text] [Related]
49. Adhesive capsulitis of the shoulder induced by protease inhibitor therapy. Three new cases. Léone J; Béguinot I; Dehlinger V; Jaussaud R; Rouger C; Strady C; Pennaforte JL; Etienne JC Rev Rhum Engl Ed; 1998 Dec; 65(12):800-1. PubMed ID: 9923053 [No Abstract] [Full Text] [Related]
50. [Lactic acidosis and hepatic mitochondrial changes during a treatment with zidovudine]. Charton-Bain MC; Flamant M; Aubertin JM; Belair MF; Gilquin J; Kazatchkine M; Bruneval P Gastroenterol Clin Biol; 1997; 21(12):979-81. PubMed ID: 9587562 [TBL] [Abstract][Full Text] [Related]
51. Metabolic acidosis and hepatic steatosis in two HIV-infected patients on stavudine (d4T) treatment. Cornejo-Juárez P; Sierra-Madero J; Volkow-Fernández P Arch Med Res; 2003; 34(1):64-9. PubMed ID: 12604378 [TBL] [Abstract][Full Text] [Related]
52. Emerging role of riboflavin in the treatment of nucleoside analogue-induced type B lactic acidosis. Dalton SD; Rahimi AR AIDS Patient Care STDS; 2001 Dec; 15(12):611-4. PubMed ID: 11788075 [TBL] [Abstract][Full Text] [Related]
53. A case of lactic acidosis caused by stavudine in an AIDS patient. Cho BC; Han SH; Choi SH; Choi JY; Chang KH; Song YG; Kim JM Korean J Intern Med; 2004 Mar; 19(1):66-9. PubMed ID: 15053048 [TBL] [Abstract][Full Text] [Related]
54. Severe metabolic acidosis and Fanconi syndrome during stavudine and abacavir therapy in a resource-limited setting. Bansie RD; Vreden SG Braz J Infect Dis; 2012; 16(6):610-1. PubMed ID: 23141987 [No Abstract] [Full Text] [Related]
55. A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome. Carr A; Miller J; Law M; Cooper DA AIDS; 2000 Feb; 14(3):F25-32. PubMed ID: 10716495 [TBL] [Abstract][Full Text] [Related]
56. [Fatal lactic acidosis in a patient infected by HIV and treated with stavudine and didanosine]. Mégarbane B; Goldgran-Tolédano D; Guérin JM; Baud F Pathol Biol (Paris); 2000 Jun; 48(5):505-7. PubMed ID: 10949849 [TBL] [Abstract][Full Text] [Related]
57. Clinical features and risk factors of lactic acidosis following long-term antiretroviral therapy: 4 fatal cases. ter Hofstede HJ; de Marie S; Foudraine NA; Danner SA; Brinkman K Int J STD AIDS; 2000 Sep; 11(9):611-6. PubMed ID: 10997508 [TBL] [Abstract][Full Text] [Related]
58. Hepatic steatosis and lactic acidosis caused by stavudine in an HIV-infected patient. Bleeker-Rovers CP; Kadir SW; van Leusen R; Richter C Neth J Med; 2000 Nov; 57(5):190-3. PubMed ID: 11063865 [TBL] [Abstract][Full Text] [Related]
59. Lactic acidosis caused by nucleoside analogues. Shiber JR Am J Emerg Med; 2005 Jul; 23(4):582-3. PubMed ID: 16032647 [No Abstract] [Full Text] [Related]
60. Gynaecomastia associated with combination antiretroviral therapy including protease inhibitors for human immunodeficiency virus infection. Post JJ Int J STD AIDS; 1999 Apr; 10(4):275-6. PubMed ID: 12035783 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]